Cargando…
Diagnosis and management of migraine in ten steps
Migraine is a disabling primary headache disorder that directly affects more than one billion people worldwide. Despite its widespread prevalence, migraine remains under-diagnosed and under-treated. To support clinical decision-making, we convened a European panel of experts to develop a ten-step ap...
Autores principales: | Eigenbrodt, Anna K., Ashina, Håkan, Khan, Sabrina, Diener, Hans-Christoph, Mitsikostas, Dimos D., Sinclair, Alexandra J., Pozo-Rosich, Patricia, Martelletti, Paolo, Ducros, Anne, Lantéri-Minet, Michel, Braschinsky, Mark, del Rio, Margarita Sanchez, Daniel, Oved, Özge, Aynur, Mammadbayli, Ayten, Arons, Mihails, Skorobogatykh, Kirill, Romanenko, Vladimir, Terwindt, Gisela M., Paemeleire, Koen, Sacco, Simona, Reuter, Uwe, Lampl, Christian, Schytz, Henrik W., Katsarava, Zaza, Steiner, Timothy J., Ashina, Messoud |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8321897/ https://www.ncbi.nlm.nih.gov/pubmed/34145431 http://dx.doi.org/10.1038/s41582-021-00509-5 |
Ejemplares similares
-
Guideline on the use of onabotulinumtoxinA in chronic migraine: a consensus statement from the European Headache Federation
por: Bendtsen, Lars, et al.
Publicado: (2018) -
European headache federation guideline on the use of monoclonal antibodies acting on the calcitonin gene related peptide or its receptor for migraine prevention
por: Sacco, Simona, et al.
Publicado: (2019) -
Correction to: European headache federation guideline on the use of monoclonal antibodies acting on the calcitonin gene related peptide or its receptor for migraine prevention
por: Sacco, Simona, et al.
Publicado: (2019) -
Health technology assessment for the acute and preventive treatment of migraine: A position statement of the International Headache Society
por: Diener, Hans Christoph, et al.
Publicado: (2021) -
Pituitary adenylate-cyclase-activating polypeptide (PACAP): another novel target for treatment of primary headaches?
por: Ashina, Messoud, et al.
Publicado: (2018)